Showing results (41-50 of 101) with videos related to
Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2' side chainsAmos B Smith, Adam K Charnley, Hironori Harada, et al.The Journal of Biological Chemistry|December 14, 2002
Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acidCathryn A Shaw-Reid, Vandna Munshi, Pia Graham, et al.Journal of Medicinal Chemistry|May 2, 2003
Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitorsAmos B Smith, Louis-David Cantin, Alexander Pasternak, et al.Bioorganic & Medicinal Chemistry Letters|May 24, 2022
Structure activity relationship of N-1 substituted 1,5-naphthyrid-2-one analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-9)Sheo B Singh, Christopher M Tan, David Kaelin, et al.ACS Chemical Biology|March 22, 2017
Affinity Selection-Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase InhibitorScott S Walker, David Degen, Elliott Nickbarg, et al.Journal of Medicinal Chemistry|September 30, 2014
Design, synthesis, structure-function relationship, bioconversion, and pharmacokinetic evaluation of ertapenem prodrugsSheo B Singh, Diane Rindgen, Prudence Bradley, et al.Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virusZhijian Lu, Joann Bohn, Tom Rano, et al.Journal of Medicinal Chemistry|April 20, 2019
Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine KinaseRoberto A Crespo, Qun Dang, Nian E Zhou, et al.Proceedings of the National Academy of Sciences of the United States of America|March 26, 2021
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testingXi He, Shuo Quan, Min Xu, et al.Bioorganic & Medicinal Chemistry Letters|August 6, 2002
Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-resistant viral strainsYuan Cheng, Fengqi Zhang, Thomas A Rano, et al.Pageof 11